case 1: treatments for nmibc refractory to bcg
Published 4 years ago • 100 plays • Length 3:20Download video MP4
Download video MP3
Similar videos
-
3:08
case 1: non-muscle invasive, bcg-refractory bladder cancer
-
8:35
case 1: novel agents in superficial bladder cancer
-
3:35
case 1: impact of the bcg shortage in bladder cancer
-
10:35
management of bcg unresponsive cystectomy ineligible bladder cancer patients pembrolizumab
-
2:45
holding my bladder during the second hour of my second bcg bladder cancer treatment
-
10:00
bcg treatment for non-muscle invasive bladder cancer
-
10:19
what is bcg immunotherapy?
-
1:39:37
management of nmibc: practical solutions for common problems
-
0:27
cretostimogene plus pembrolizumab for bcg-unresponsive nmibc with cis #bladdercancer #cancer #news
-
28:32
bcg treatment for high grade, non-muscle invasive bladder cancer
-
3:31
what is intravesical therapy? | bladder cancer advocacy network
-
4:46
case 1: use of blue light cystoscopy in bladder cancer
-
7:41
bcg-refractory superficial bladder cancer
-
28:30
high grade non muscle invasive bladder cancer: stages and treatment including bcg
-
9:21
bcg failure: defining failure and managing difficult cases of non-muscle invasive bladder cancer
-
11:45
emerging treatments for bcg unresponsive non-muscle invasive bladder cancer
-
1:01
treatment options for bladder cancer | ohio state medical center
-
8:24
case 2: combination therapy for cis-ineligible bladder cancer
-
51:36
treatment of high risk nmibc in era of bcg shortage - empire urology lecture series
-
43:50
urowebinar: new treatments development in nmibc
-
1:06
dr. petrylak discusses bcg for the treatment of patients with non-invasive bladder cancer
-
3:04
high-risk, bcg-unresponsive nmibc beyond rc: intravesical and systemic therapies